Last updated: 2026-09-09 04:52:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Amneal Pharmaceuticals, Inc. (AMRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $17,05, with a market capitalization of $6,07B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9,49 to $19,26. This page covers its latest market performance, valuation, price trends and company information.
$6,07B | |
$17,27 | |
$24,48 | |
$1,24 | |
$17,44 | |
1,38M | |
2,01M | |
-- | |
$19,26 | |
$9,49 | |
-- | |
-- |
Amneal Pharmaceuticals, Inc. (AMRX) last closed at $17,44 as of 2026-09-08 23:31:00, unchanged from the previous close of $17,44.
During the latest regular trading session, AMRX traded between $1,24 and $24,48, with a volume of 1,38M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Amneal Pharmaceuticals, Inc. (AMRX) moved from $18,01 to $17,05, representing a decline of 5,32% ($0,96).
The stock traded between $17,00 and $18,32 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1,74 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 77,4%
AMRX is currently trading at $17,05, placing it 77,4% of the way from its 52-week low of $9,49 to its 52-week high of $19,26. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8500 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Amneal Pharmaceuticals, Inc. (AMRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.